Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure

BACKGROUND: Tolvaptan, a vasopressin V(2) receptor blocker, has a diuretic effect for patients with heart failure. However, there were a few data concerning the effects of tolvaptan in patients with chronic kidney disease (CKD). METHODS: We retrospectively analyzed 21 patients with chronic heart fai...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Nephrol
Hlavní autoři: Katsumata, Mari, Hirawa, Nobuhito, Sumida, Koichiro, Kagimoto, Minako, Ehara, Yosuke, Okuyama, Yuki, Fujita, Megumi, Fujiwara, Akira, Kobayashi, Mayumi, Kobayashi, Yusuke, Yamamoto, Yuichiro, Saka, Sanae, Yatsu, Keisuke, Fujikawa, Tetsuya, Toya, Yoshiyuki, Yasuda, Gen, Tamura, Kouichi, Umemura, Satoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Japan 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648735/
https://ncbi.nlm.nih.gov/pubmed/28190113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-016-1379-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky